NO309814B1 - Zwitterionformer av trovafloxacin, fremgangsmÕte for fremstilling derav og preparat inneholdende disse - Google Patents

Zwitterionformer av trovafloxacin, fremgangsmÕte for fremstilling derav og preparat inneholdende disse Download PDF

Info

Publication number
NO309814B1
NO309814B1 NO980862A NO980862A NO309814B1 NO 309814 B1 NO309814 B1 NO 309814B1 NO 980862 A NO980862 A NO 980862A NO 980862 A NO980862 A NO 980862A NO 309814 B1 NO309814 B1 NO 309814B1
Authority
NO
Norway
Prior art keywords
polymorph
hygroscopic
compound
approx
trovafloxacin
Prior art date
Application number
NO980862A
Other languages
English (en)
Norwegian (no)
Other versions
NO980862L (no
NO980862D0 (no
Inventor
Douglas John Meldrum Allen
David Bruning Joseph
Timothy Norris
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO980862L publication Critical patent/NO980862L/no
Publication of NO980862D0 publication Critical patent/NO980862D0/no
Publication of NO309814B1 publication Critical patent/NO309814B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Physical Water Treatments (AREA)
  • Processing Of Solid Wastes (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO980862A 1995-08-29 1998-02-27 Zwitterionformer av trovafloxacin, fremgangsmÕte for fremstilling derav og preparat inneholdende disse NO309814B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US297595P 1995-08-29 1995-08-29
PCT/IB1996/000756 WO1997007800A1 (fr) 1995-08-29 1996-07-29 Formes zwitterioniques de trovafloxacine

Publications (3)

Publication Number Publication Date
NO980862L NO980862L (no) 1998-02-27
NO980862D0 NO980862D0 (no) 1998-02-27
NO309814B1 true NO309814B1 (no) 2001-04-02

Family

ID=21703460

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980862A NO309814B1 (no) 1995-08-29 1998-02-27 Zwitterionformer av trovafloxacin, fremgangsmÕte for fremstilling derav og preparat inneholdende disse

Country Status (30)

Country Link
EP (1) EP0850060A1 (fr)
JP (1) JP3188476B2 (fr)
KR (1) KR100343909B1 (fr)
CN (1) CN1190889A (fr)
AP (1) AP636A (fr)
AR (1) AR003985A1 (fr)
AU (1) AU704115B2 (fr)
BR (1) BR9609998A (fr)
CA (1) CA2229786C (fr)
CO (1) CO4480739A1 (fr)
CZ (1) CZ56698A3 (fr)
DZ (1) DZ2087A1 (fr)
GT (1) GT199600072A (fr)
HR (1) HRP960395B1 (fr)
HU (1) HUP9900170A3 (fr)
IL (1) IL122651A (fr)
MA (1) MA23966A1 (fr)
MY (1) MY113874A (fr)
NO (1) NO309814B1 (fr)
NZ (1) NZ312199A (fr)
OA (1) OA10669A (fr)
PE (1) PE12598A1 (fr)
PL (1) PL325170A1 (fr)
RU (1) RU2144921C1 (fr)
SK (1) SK23898A3 (fr)
TN (1) TNSN96109A1 (fr)
TR (1) TR199800339T1 (fr)
WO (1) WO1997007800A1 (fr)
YU (1) YU48396A (fr)
ZA (1) ZA967282B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000106A (es) 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
US7019142B2 (en) 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino
US6114531A (en) * 1998-07-28 2000-09-05 Pfizer Inc. Process for preparing quinolone and naphthyridone carboxylic acids
HN1999000141A (es) * 1998-09-03 2000-06-19 Pfizer Prod Inc Procedimiento para preparar sales de trovafloxacina de adicion de acidos.
US6239141B1 (en) 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS274601B2 (en) * 1983-07-27 1991-09-15 Dainippon Pharmaceutical Co Method of 1,8-naphthyridine derivative production
NZ232091A (en) * 1989-01-16 1990-12-21 Bellon Labor Sa Roger 7-fluoro-8-(piperazin-1-yl)-4-oxo-1,4-dihydro-benzo(b)(1,8)naphthyridine-3-carboxylic acid derivatives, preparation and pharmaceutical compositions thereof
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5939550A (en) 1995-06-15 1999-08-17 Pfizer Inc. Process for preparing derivatives of azabicyclo naphthyridine carboxylic acid comprising a dipeptide

Also Published As

Publication number Publication date
SK23898A3 (en) 1999-05-07
MX9801664A (es) 1998-08-30
KR100343909B1 (ko) 2003-04-10
HRP960395A2 (en) 1998-06-30
PL325170A1 (en) 1998-07-06
MA23966A1 (fr) 1997-04-01
OA10669A (en) 2000-11-06
ZA967282B (en) 1998-03-02
HUP9900170A2 (hu) 1999-05-28
AU704115B2 (en) 1999-04-15
AU6367696A (en) 1997-03-19
EP0850060A1 (fr) 1998-07-01
AR003985A1 (es) 1998-09-30
MY113874A (en) 2002-06-29
CZ56698A3 (cs) 1999-02-17
YU48396A (sh) 1998-12-23
KR19990044232A (ko) 1999-06-25
JP3188476B2 (ja) 2001-07-16
NO980862L (no) 1998-02-27
AP9600853A0 (en) 1996-10-31
CO4480739A1 (es) 1997-07-09
CA2229786A1 (fr) 1997-03-06
TR199800339T1 (xx) 1998-06-22
PE12598A1 (es) 1998-03-20
BR9609998A (pt) 1999-07-06
GT199600072A (es) 1998-02-14
CN1190889A (zh) 1998-08-19
HUP9900170A3 (en) 1999-11-29
DZ2087A1 (fr) 2002-07-22
JPH10511692A (ja) 1998-11-10
HRP960395B1 (en) 2001-12-31
WO1997007800A1 (fr) 1997-03-06
CA2229786C (fr) 2002-02-19
TNSN96109A1 (fr) 2005-03-15
RU2144921C1 (ru) 2000-01-27
IL122651A (en) 2000-02-17
NO980862D0 (no) 1998-02-27
IL122651A0 (en) 1998-08-16
AP636A (en) 1998-04-09
NZ312199A (en) 1999-06-29

Similar Documents

Publication Publication Date Title
RU2125571C1 (ru) СОЛЬ 7-([1α,5α,6α]-6-АМИНО-3-АЗАБИЦИКЛО [3.1.0] ГЕКС-3-ИЛ)-6-ФТОР-1-(2,4-ДИФТОРФЕНИЛ)-1,4- ДИГИДРО-4-ОКСО-1,8-НАФТИРИДИН-3-КАРБОНОВОЙ И МЕТАНСУЛЬФОНОВОЙ КИСЛОТ И СПОСОБ ЕЕ ПОЛУЧЕНИЯ
CS272767B2 (en) Method of benzimidazole derivatives production
NO311891B1 (no) Nye krystallinske cefem-syreaddisjonssalter og fremgangsmåte for deres fremstilling
KR100343909B1 (ko) 트로바플록사신의쯔비터이온형태
US6066647A (en) Zwitterionic forms of trovafloxacin
CZ284837B6 (cs) 3/2 hydrát a anhydrát 7-/(7-(S)-amino-5-azaspiro/2.4/-heptan-5-yl/-8-chlor-6-fluor-1-/(1R,2S)-2-fluorcyklopropyl/-4-oxo-1,4-dihydrochinolin-3-karboxylové kyseliny, způsoby selektivní výroby 3/2 hydrátu, jeho krystaly a antibakteriální činidla na jeho bázi
JPH085863B2 (ja) １４−アニソイルアコニンおよびそれを有効成分とする新規な鎮痛・抗炎症剤
US4764517A (en) 8α-(N,N-diethylsulfamoylamino)-6-n-propyl ergoline useful as a prolactin secretion inhibitor, anti-parkinson, anti-depressant agent
KR100274736B1 (ko) 6-엔-(엘-에이엘에이-엘-에이엘에이)-트로바플록사신 전구약물의 폴리모프
EP1598347A1 (fr) Polymorphes du sel de sodium de pantoprazole et procédé de préparation
CZ20014270A3 (cs) Polymorfy krystalického citrátu (2-benzhydryl-1-azabicyklo[2.2.2]oct-3-yl)-(5-iso-propyl-2-methoxybenzyl)-aminu jako antagonisté receptoru NK-1
AP788A (en) Novel crystal form of anhydrous 7-(1a, 5a, 6a)-6-Amino-3-Azabicyclo(3.1.0) hex-3-YI)-6-Fluoro-1-(2,4- Difluorophenyl)-1,4-Dihydro-4-Oxo-1, 8-Naphthyridine-3-Carboxylic Acid, Methanesulfonic acid salt.
CZ287729B6 (en) Aminoalkyl aminopyridine derivatives, process of their preparation and pharmaceutical preparation in which they are comprised
CN120917008A (zh) 新型乙酰胆碱酯酶抑制剂及其用于预防和治疗强迫症和神经变性疾病的用途
MXPA98001665A (en) Polymorphoses of profarmaco of 6-n- (l-ala-l-ala) -trovafloxacin, procedure for its preparation and use of mis
CS235970B2 (cs) Způsob výroby 2-guanidino-4-triazolylthiazolů
CS226200B2 (cs) Způsob výroby derivátů 4-amino-5-alkylsulfonylorthoanisamidů

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application